4//SEC Filing
Arthur David J. 4
Accession 0001615219-20-000122
CIK 0001615219other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:05 PM ET
Size
5.4 KB
Accession
0001615219-20-000122
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2020-12-02+275,000→ 275,000 totalExercise: $0.74Exp: 2030-12-01→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001769331
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:05 PM ET
- Size
- 5.4 KB